Contemporary cardiovascular device clinical trials (trends and patterns 2001 to 2012).

[1]  M. Reynolds,et al.  Trends in Coronary Revascularization Procedures Among Medicare Beneficiaries Between 2008 and 2012 , 2015, Circulation.

[2]  N. Marshall,et al.  Ethics, consent and blinding: lessons from a placebo/sham controlled CPAP crossover trial , 2015, Thorax.

[3]  E. Dorsey,et al.  The anatomy of medical research: US and international comparisons. , 2015, JAMA.

[4]  William T. Abraham,et al.  Trials of implantable monitoring devices in heart failure: which design is optimal? , 2014, Nature Reviews Cardiology.

[5]  A. Bernard,et al.  Methodological choices for the clinical development of medical devices , 2014, Medical devices.

[6]  Stuart J Pocock,et al.  Current challenges for clinical trials of cardiovascular medical devices. , 2014, International journal of cardiology.

[7]  Deepak L. Bhatt,et al.  Unintentional overestimation of an expected antihypertensive effect in drug and device trials: mechanisms and solutions. , 2014, International journal of cardiology.

[8]  Ralph B D'Agostino,et al.  Stenting and medical therapy for atherosclerotic renal-artery stenosis. , 2014, The New England journal of medicine.

[9]  D. J. Veldhuisen,et al.  Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions , 2014, Heart Failure Reviews.

[10]  F. Vermassen,et al.  Standardized definitions and clinical endpoints in trials investigating endovascular repair of aortic dissections. , 2013, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[11]  Sandeep K. Krishnan,et al.  Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients. , 2013, American journal of hypertension.

[12]  S. Saito,et al.  Global cardiovascular device innovation: Japan-USA synergies: Harmonization by Doing (HBD) program, a consortium of regulatory agencies, medical device industry, and academic institutions. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[13]  Manesh R. Patel,et al.  Intra-aortic balloon pump trials: questions, answers, and unresolved issues. , 2013, Circulation. Cardiovascular interventions.

[14]  V. Howard,et al.  Interventions to Increase Enrollment in a Large Multicenter Phase 3 Trial of Carotid Stenting Vs. Endarterectomy , 2012, International journal of stroke : official journal of the International Stroke Society.

[15]  Manesh R. Patel,et al.  Clinical Trials in Peripheral Vascular Disease: Pipeline and Trial Designs An Evaluation of the ClinicalTrials.gov Database , 2012, Circulation.

[16]  Aaron S Kesselheim,et al.  Regulation of medical devices in the United States and European Union. , 2012, The New England journal of medicine.

[17]  M. Borggrefe,et al.  Intrathoracic Impedance Monitoring, Audible Patient Alerts, and Outcome in Patients With Heart Failure , 2011, Circulation.

[18]  R. Redberg,et al.  Medical devices--balancing regulation and innovation. , 2011, The New England journal of medicine.

[19]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.

[20]  J. Ornato,et al.  ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2008, Heart rhythm.

[21]  Salim Yusuf,et al.  Sensible guidelines for the conduct of large randomized trials , 2008, Clinical trials.

[22]  D Elbourne,et al.  Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study. , 2007, Health technology assessment.

[23]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.